Form 4: Vistagen Therapeutics CFO Acquires Shares Through Employee Stock Purchase Plan

Cynthia Anderson, CFO of Vistagen Therapeutics, acquired 2,592 shares of common stock through the company's Employee Stock Purchase Plan.

Summary

• Cynthia Anderson, the Chief Financial Officer of Vistagen Therapeutics, acquired 2,592 shares of the company's common stock.
• The shares were acquired through the company's 2019 Employee Stock Purchase Plan, as amended.
• The transaction occurred on December 31, 2024.
• The price per share was $2.5075.
• Following the transaction, Ms. Anderson directly owns 6,184 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The transaction is a routine acquisition of shares by an executive, which is generally seen as a positive sign of confidence, but it's not a major event.

Positives

• The acquisition of shares by a key executive like the CFO can be seen as a positive sign of confidence in the company's future.

Industry Context

This type of transaction is common for executives who participate in employee stock purchase plans. It reflects a standard practice for aligning executive interests with shareholder value.

Comparison to Industry Standards

• Employee stock purchase plans are a common practice across the biotechnology industry, with many companies offering similar programs to their employees.
• The share price of $2.5075 is specific to Vistagen Therapeutics and would need to be compared to other similar companies in the sector to assess its relative value.

Stakeholder Impact

• The acquisition of shares by the CFO may be viewed positively by shareholders as it indicates confidence in the company's prospects.

Key Dates

Keywords

Vistagen Therapeutics, Cynthia Anderson, Employee Stock Purchase Plan, Share Acquisition, VTGN, CFO, Insider Trading